Market Access News | pharmaphorum

Sunday 24 November 2024

Channels

Content type

Categories

Categories

Sort by

Order

News

News

breast cancer awareness campaign - women in front of Westminster

UK celeb seeks funds to challenge NICE's Enhertu verdict

UK actor and TV personality Nadia Sawalha is spearheading a fundraising effort to launch an appeal against the recent rejection of a breast cancer therapy by cost-effectiveness agency NICE.

News

FDA knocks back Zealand's dasiglucagon once again

Zealand Pharma has suffered another setback in its bid to bring glucagon receptor agonist dasiglucagon for ultra-rare disease congenital hyperinsulinism (CHI) to the US market.

News

thumbs down

NICE turns down Takeda colorectal cancer drug

Takeda's recently approved advanced colorectal cancer therapy Fruzaqla has been rejected by NICE for use by the NHS on the grounds that it is not cost-effective.

News

Eli Lilly worker holding Zepbound

Mounjaro and Zepbound shortages over, declares FDA

The US Food and Drug Administration (FDA) has declared an end to the shortage of tirzepatide, the active ingredient in

News

FDA approval gives BMS an edge in NSCLC treatment

FDA approval gives BMS an edge in NSCLC treatment

Bristol Myers Squibb (BMS) has secured

News

Gilead strikes deal to expand HIV drug access in 120 countries

Gilead strikes deal to expand HIV drug access in 120 countri...

Gilead Sciences has taken a major step towards increasing global access to HIV prevention with the signing of royalty-free